Department of Otorhinolaryngology, Head and Neck Surgery, University Hospitals of Leuven, Leuven, Belgium.
Department of Neurosciences, Research Group Experimental Oto-Rhino-Laryngology, Leuven, Belgium.
J Int Adv Otol. 2024 May 23;20(3):225-230. doi: 10.5152/iao.2024.231122.
The aim of this article is to determine the efficacy of otoendoscopy during microscopic cholesteatoma surgery on residual cholesteatoma rates postoperatively. The medical records of patients (aged 4-90) with primary acquired cholesteatoma who underwent microscopic cholesteatoma surgery (exclusively transcanal approach or canal wall-up tympano-mastoidectomy) with subsequent otoendoscopic examination (80 ears) for intraoperative cholesteatoma residues were retrospectively reviewed. All cases with mixed microscopic/endoscopic, fully endoscopic, or fully microscopic dissection were excluded, as well as cases where a canal wall-down technique was used. After microscopic cholesteatoma removal, the otoendoscope was used to inspect the middle ear recesses for intraoperative cholesteatoma residues. The intra- and postoperative cholesteatoma residue rate were evaluated. On endoscopic examination, intraoperative cholesteatoma residues were encountered in 24 patients (30%). A total of 30 foci were detected. Most of them were found in the superior retrotympanum (15 foci). In 9 cases an antral remnant guided the surgeon to convert to a canal wall up tympanomastoidectomy. During the postoperative follow-up period, residual cholesteatoma was detected on postoperative magnetic resonance imaging in 6 patients (7.5%). Adding an otoendoscopic examination to microscopic cholesteatoma surgery reduced the postoperative cholesteatoma residues rate (odds ratio=0.16). A negative otoendoscopic examination led to a cholesteatoma residue-free follow-up period in 95% of cases(NPV=0.95). Otoendoscopy is effective in identifying intraoperative cholesteatoma residues after microscopic cholesteatoma surgery. It reduces the postoperative cholesteatoma residue rate, and a negative otoendoscopic examination increases the likelihood of a cholesteatoma residue-free follow-up.
本文旨在确定耳内镜在显微镜下胆脂瘤手术中对术后残余胆脂瘤率的疗效。回顾性分析了 80 例(年龄 4-90 岁)接受单纯经耳道入路或完壁式鼓室乳突切开术显微镜下胆脂瘤手术(排除混合显微镜/内镜、全内镜、全显微镜切除的病例,以及使用鼓室切开术的病例),并随后行耳内镜检查(术中检查残余胆脂瘤)的原发性获得性胆脂瘤患者的病历。在显微镜下胆脂瘤切除后,使用耳内镜检查中耳隐窝以检查术中胆脂瘤残余物。评估了术中及术后胆脂瘤残留率。在内镜检查中,24 例(30%)患者发现术中胆脂瘤残留。共发现 30 个病灶,大部分位于后上鼓室(15 个病灶)。9 例因存在鼓窦残余物而改行完壁式乳突切开术。术后磁共振成像检查发现 6 例(7.5%)患者存在残余胆脂瘤。在显微镜下胆脂瘤手术中增加耳内镜检查可降低术后胆脂瘤残留率(比值比=0.16)。阴性耳内镜检查可使 95%的病例在随访期间无胆脂瘤残留(NPV=0.95)。耳内镜在显微镜下胆脂瘤手术后可有效识别术中胆脂瘤残余物。它降低了术后胆脂瘤残留率,阴性耳内镜检查增加了无胆脂瘤残留的随访可能性。